# Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck

> **NCT00185835** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** ZD-1839
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00185835
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2006-07
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185835, "Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00185835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*